BioMatrix Specialty Pharmacy Appoints Kathee Kramm as CEO in Strategic Leadership Transition

Plantation, FL, January 02, 2024 (PRNewswire) -- BioMatrix Specialty Pharmacy is pleased to announce the appointment of Kathee Kramm as Chief Executive Officer, succeeding the founder and former CEO, Nick Karalis. Kathee has been BioMatrix’s President and CEO after founding and leading AxelaCare Health Solutions. This significant transition follows a comprehensive year-long succession plan, poised to accelerate BioMatrix's expansion in the specialty infusion sector.

Read full article here.